Alkem Laboratories Ltd (ALKEM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alkem Laboratories Ltd (ALKEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9778
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company’s products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, diabetes, malaria, pain, cardiovascular diseases and immune disorders. It offers vitamins, minerals and nutrition products. The company distributes its products through a wide network of distributors all over India. It exports products to Europe, Australia, South-East Asia, North America, South America, Russia-CIS and Africa. Alkem is headquartered in Mumbai, Maharashtra, India.

Alkem Laboratories Ltd (ALKEM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Alkem Labs Acquires Formulation Manufacturing Facility from Long Pharma 13
Alkem Labs Acquires Manufacturing Assets from NORAC 14
Partnerships 15
Alkem Labs Enters into Agreement with Haw Par 15
Licensing Agreements 16
Alkem Labs Enters into Licensing Agreement with Stempeutics Research 16
Alkem Enters into Licensing Agreement with MediPost for Cartistem 17
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 18
Equity Offering 19
Alkem Labs Raises USD202 Million in IPO 19
Asset Transactions 21
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 21
Acquisition 22
Alkem Labs Acquires 51% Stake in Cachet Pharma 22
Alkem Labs Acquires 51% Stake in Indchemie Health Specialities 23
Alkem Labs Acquires Remaining 20% Stake in Enzene Biosciences 24
Alkem Labs Acquires Remaining 80% Stake in Pharmacor from S&B 25
Alkem Laboratories Ltd – Key Competitors 26
Alkem Laboratories Ltd – Key Employees 27
Alkem Laboratories Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
May 30, 2018: Alkem reports Q4FY18 and FY18 Results 30
Aug 11, 2017: Alkem Reports Q1FY18 Results 32
Corporate Communications 33
Oct 31, 2017: Alkem Laboratories: Resignation of Chief Executive Officer (CEO) 33
May 17, 2017: Alkem Laboratories Announces resignation of Independent Director 34
Legal and Regulatory 35
Aug 11, 2018: Alkem Laboratories provides update on the US FDA Inspection at Manufacturing Facility at California, USA 35
Aug 10, 2018: Update on US FDA inspection at Alkem’s Baddi Facility 36
Jul 24, 2018: Alkem receives EIR from the US FDA for its Daman formulation facility 37
Mar 28, 2018: Alkem Labs: Update on USFDA Inspection at its manufacturing facility at Amaliya in India 38
Jan 10, 2018: Update on US FDA Inspection at Alkem’s Baddi Facility 39
Jan 10, 2018: Alkem receives EIR from the US FDA for its Baddi formulation facility 40
Oct 28, 2017: US FDA completes inspection at Alkem Laboratories’s St Louis facility 41
Sep 18, 2017: Alkem Announces Update on US FDA Inspection at Alkem’s Baddi Facility 42
Jul 14, 2017: Update on US FDA inspection for Bioequivalence Facility at Taloja 43
May 23, 2017: Alkem receives EIR from the US FDA for its Baddi Management Manufacturing Facility 44
Mar 29, 2017: Alkem receives EIR from the US FDA for its Alkem’s Ankaleshwar API Facility 45
Mar 10, 2017: Alkem Laboratories Announces Update on US FDA Inspection at Alkem s Baddi Facility 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Alkem Labs Acquires Formulation Manufacturing Facility from Long Pharma 13
Alkem Labs Acquires Manufacturing Assets from NORAC 14
Alkem Labs Enters into Agreement with Haw Par 15
Alkem Labs Enters into Licensing Agreement with Stempeutics Research 16
Alkem Enters into Licensing Agreement with MediPost for Cartistem 17
Dong-A Pharma Enters Into Licensing Agreement With Alkem Labs For DA-1229 18
Alkem Labs Raises USD202 Million in IPO 19
Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 21
Alkem Labs Acquires 51% Stake in Cachet Pharma 22
Alkem Labs Acquires 51% Stake in Indchemie Health Specialities 23
Alkem Labs Acquires Remaining 20% Stake in Enzene Biosciences 24
Alkem Labs Acquires Remaining 80% Stake in Pharmacor from S&B 25
Alkem Laboratories Ltd, Key Competitors 26
Alkem Laboratories Ltd, Key Employees 27
Alkem Laboratories Ltd, Subsidiaries 28

List of Figures
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alkem Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Alkem Laboratories Ltd (ALKEM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Beverages & More Inc:企業の戦略的SWOT分析
    Beverages & More Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cameco Corporation:企業の戦略・SWOT・財務情報
    Cameco Corporation - Strategy, SWOT and Corporate Finance Report Summary Cameco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EOS imaging SA (EOSI):医療機器:M&Aディール及び事業提携情報
    Summary EOS imaging SA (EOS Imaging) is an orthopedic imaging company that designs, develops, and markets EOS patented medical imaging system. EOS captures whole body images of a standing patient in a single scan without any stitching or vertical distortion. Through EOS, the company provides the ful …
  • Metropolis Healthcare Ltd-医療機器分野:企業M&A・提携分析
    Summary Metropolis Healthcare Ltd (Metropolis Healthcare) is a healthcare service provider that provides pathology testing services. The center provides tests and test combinations, which ranges from routine screening tests to specialized molecular and genetic assays. It also specializes in clinical …
  • Neiman Marcus Group LTD LLC:企業の戦略的SWOT分析
    Neiman Marcus Group LTD LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • HITT Contracting Inc:企業の戦略的SWOT分析
    HITT Contracting Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Zeltiq Aesthetics Inc (ZLTQ):企業の財務・戦略的SWOT分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Surge Energy Inc (SGY):企業の財務・戦略的SWOT分析
    Summary Surge Energy Inc (Surge) is an oil and gas company that offers acquisitions, exploration and production of crude oil and natural gas reserves. The company provides risk management and risk development drilling services. Its oil and natural gas producing properties include Shaunavon and Dodsl …
  • Woolworths Ltd (WOW):企業の財務・戦略的SWOT分析
    Woolworths Ltd (WOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TransCanada Corp:企業の戦略・SWOT・財務情報
    TransCanada Corp - Strategy, SWOT and Corporate Finance Report Summary TransCanada Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Centene Corp (CNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Dome Energy AB (DOME):企業の財務・戦略的SWOT分析
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • RBC Wealth Management:企業の戦略・SWOT・財務分析
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Groupama Assurances Mutuelles:企業の戦略的SWOT分析
    Groupama Assurances Mutuelles - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • HNI Corp (HNI):企業の財務・戦略的SWOT分析
    HNI Corp (HNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lumenis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Lumenis Ltd (Lumenis), a subsidiary of XIO Group, is an energy-based medical device company for aesthetic, surgical and ophthalmic applications in the field of minimally invasive clinical solutions. It manufactures and distributes medical and aesthetic lasers and light-based systems. Its maj …
  • Unilab (Philippines) Inc:企業の戦略的SWOT分析
    Unilab (Philippines) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆